JPET Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CUSHNY, A. R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by CUSHNY, A. R.
Journal of Pharmacology And Experimental Therapeutics, Vol. 11, Issue 2, 103-131, 1918
Copyright © 1918 by American Society for Pharmacology and Experimental Therapeutics


DIGITALIS IN AURICULAR FIBRILLATION

ARTHUR R. CUSHNY 1

1 From the Pharmacological Laboratory, University College, London

1. Two different types of effects are seen in the mammalian heart under the action of the digitalis series.

A. In the normal heart digitalis causes slowing through stimulation of the inhibitory centre in the medulla, and if this is eliminated, the dominant feature is an increase in the excitability which leads to the inception of independent rhythm in the auricle and ventricle, and later to discharges from different points of the same chamber, which culminate in fibrillation.

B. In the excised mammalian heart exhausted by prolonged perfusion with Ringer's solution, digitalis causes slowing and block which closely simulates that induced by inhibition in the normal heart, but which is not prevented by atropine and therefore arises from direct action on the heart. The pace-maker emits fewer impulses and these are still further reduced owing to impaired conduction to the auricle from the Keith-Flack node and to the ventricle from the auricle. The auriculo-ventricular block becomes further developed, the ventricular beats become slower and finally the chamber ceases in more or less complete systole without fibrillation.

2. In auricular fibrillation in man, digitalis slows the pulse and this is independent of the inhibitory mechanism, for it is not prevented by atropine. In the mammalian heart in situ when auricular fibrillation is induced, strophanthin finally arrests the irregularity of the ventricle, by impairing conduction, but the pulse is not slowed owing to the accelerated idioventricular rhythm induced by the drug. In auricular fibrillation induced in the perfused heart, strophanthin renders the ventricle regular through impaired auriculo-ventricular conduction and at the same time slows its rate.

3. The type A, inhibitory slowing, occurs in man and animals with normal cardiac rhythm. The type B, slowing through direct cardiac action, occurs in most cases of auricular fibrillation in man, in rare cases of normal rhythm in man, in the perfused mammalian heart, whether the normal rhythm is preserved or the auricle is fibrillating, and in the frog.

4. The primary cause of the type B in man and animals is the malnutrition of the heart; the auricular fibrillation merely favours its appearance by accentuating the fundamental cardiac malnutrition.




This article has been cited by other articles:


Home page
Arch Intern MedHome page
H. M. KORNS
DELAYED CONDUCTION THROUGH THE RIGHT AND LEFT BRANCHES OF THE ATRIOVENTRICULAR BUNDLE
Arch Intern Med, August 1, 1922; 30(2): 158 - 170.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1918 by the American Society for Pharmacology and Experimental Therapeutics.